Artisan Partners’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-481,853
Closed -$20.4M 335
2022
Q4
$20.4M Sell
481,853
-509,408
-51% -$21M 0.04% 253
2022
Q3
$31.8M Sell
991,261
-427,273
-30% -$15M 0.06% 236
2022
Q2
$46.1M Sell
1,418,534
-982,746
-41% -$31.8M 0.08% 218
2022
Q1
$86.9M Sell
2,401,280
-244,461
-9% -$8.39M 0.11% 182
2021
Q4
$105M Sell
2,645,741
-126,587
-5% -$5.28M 0.12% 169
2021
Q3
$121M Sell
2,772,328
-488,554
-15% -$21.9M 0.15% 151
2021
Q2
$133M Sell
3,260,882
-53,300
-2% -$2.06M 0.16% 148
2021
Q1
$109M Sell
3,314,182
-623,692
-16% -$23.5M 0.14% 162
2020
Q4
$160M Sell
3,937,874
-318,132
-7% -$11.9M 0.2% 133
2020
Q3
$156M Sell
4,256,006
-77,974
-2% -$2.82M 0.22% 118
2020
Q2
$147M Buy
4,333,980
+764,571
+21% +$20.8M 0.24% 114
2020
Q1
$75.6M Sell
3,569,409
-164,714
-4% -$3.67M 0.16% 137
2019
Q4
$83.4M Sell
3,734,123
-111,988
-3% -$2.44M 0.15% 139
2019
Q3
$77.9M Buy
+3,846,111
New +$75.8M 0.15% 142

Other funds holding GMAB

Artisan Partners's GMAB Position: Q1 2023 in Review

Artisan Partners sold out of Genmab (GMAB) in Q1 2023, closing a stake of 481,853 shares — an estimated $20.4M sold.

Artisan Partners first reported a position in GMAB in Q3 2019 and held it in 14 quarters. The position peaked at $160M in Q4 2020. 216 funds tracked by Wall St. Rank hold GMAB as of Q1 2023.

  • Artisan Partners reported no remaining Genmab position as of Q1 2023 after selling out during the quarter.
  • Artisan Partners sold 481,853 Genmab shares in Q1 2023, an estimated $20.4M.
  • Artisan Partners first reported a position in Genmab in Q3 2019 and held it in 14 quarters.
  • Artisan Partners's Genmab position peaked at $160M in Q4 2020.
  • 216 funds tracked by Wall St. Rank held Genmab as of Q1 2023.

Based on Artisan Partners's 13F filing for Q1 2023, filed 11 May 2023.